MAP3K1 and neoplasm: However, the longest-responding patient, whose tumor harbored a MAP3K1 L380S mutation, was excluded in this analysis, despite the fact that this is a recurrent mutation in breast cancer (AACR GENIE data v4.1), suggesting it is a loss-of-function mutation.